Hybio Pharmaceutical Cash Flow Quality Index
Hybio Pharmaceutical cash flow quality index. Hybio Pharmaceutical (300199) has a Cash Flow Quality Index of 1.54x as of June 2025. Operating cash flow of CN¥116.72 Million exceeds net income of CN¥75.60 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Hybio Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hybio Pharmaceutical (2008–2021)
Cash flow quality index of Hybio Pharmaceutical from 2008 to 2021. Historical Cash Flow Quality Index for Hybio Pharmaceutical across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Hybio Pharmaceutical to measure how much of total assets are equity-financed.
Hybio Pharmaceutical Cash Flow Quality Index by Year (2008–2021)
Hybio Pharmaceutical cash flow quality index by year from 2008 to 2021. Year-by-year earnings quality comparison for Hybio Pharmaceutical. For the full cash flow conversion analysis, see how efficiently does Hybio Pharmaceutical generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 5.52x | CN¥156.83 Million | CN¥28.44 Million | ▲ +750.8% |
| 2017 | 0.65x | CN¥213.74 Million | CN¥329.72 Million | ▼ -36.2% |
| 2016 | 1.02x | CN¥296.41 Million | CN¥291.92 Million | ▲ +123.3% |
| 2015 | 0.45x | CN¥138.84 Million | CN¥305.34 Million | ▼ -49.2% |
| 2014 | 0.89x | CN¥153.43 Million | CN¥171.56 Million | ▼ -24.3% |
| 2013 | 1.18x | CN¥153.48 Million | CN¥129.93 Million | ▲ +21.7% |
| 2012 | 0.97x | CN¥87.19 Million | CN¥89.80 Million | ▲ +7.8% |
| 2011 | 0.90x | CN¥72.48 Million | CN¥80.47 Million | ▼ -13.0% |
| 2010 | 1.03x | CN¥54.69 Million | CN¥52.85 Million | ▲ +40.2% |
| 2009 | 0.74x | CN¥26.11 Million | CN¥35.37 Million | ▼ -68.0% |
| 2008 | 2.30x | CN¥45.75 Million | CN¥19.86 Million | — |